000 | 01805 a2200505 4500 | ||
---|---|---|---|
005 | 20250517022311.0 | ||
264 | 0 | _c20151016 | |
008 | 201510s 0 0 eng d | ||
022 | _a1932-6203 | ||
024 | 7 |
_a10.1371/journal.pone.0120856 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aPereira, Renata C | |
245 | 0 | 0 |
_aOsteocytic protein expression response to doxercalciferol therapy in pediatric dialysis patients. _h[electronic resource] |
260 |
_bPloS one _c2015 |
||
300 |
_ae0120856 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 | _aAdaptor Proteins, Signal Transducing |
650 | 0 | 4 | _aAdolescent |
650 | 0 | 4 | _aBiopsy |
650 | 0 | 4 |
_aBone Density Conservation Agents _xpharmacology |
650 | 0 | 4 |
_aBone Morphogenetic Proteins _xgenetics |
650 | 0 | 4 |
_aBone and Bones _xdrug effects |
650 | 0 | 4 | _aChild |
650 | 0 | 4 |
_aErgocalciferols _xpharmacology |
650 | 0 | 4 |
_aExtracellular Matrix Proteins _xgenetics |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aFibroblast Growth Factor-23 |
650 | 0 | 4 |
_aFibroblast Growth Factors _xgenetics |
650 | 0 | 4 | _aGene Expression |
650 | 0 | 4 |
_aGenetic Markers _xgenetics |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aKidney Failure, Chronic _xcomplications |
650 | 0 | 4 | _aMale |
650 | 0 | 4 |
_aOsteocytes _xmetabolism |
650 | 0 | 4 |
_aOsteolysis _xblood |
650 | 0 | 4 |
_aPhosphoproteins _xgenetics |
650 | 0 | 4 |
_aRenal Dialysis _xadverse effects |
650 | 0 | 4 | _aTreatment Outcome |
700 | 1 | _aJüppner, Harald | |
700 | 1 | _aGales, Barbara | |
700 | 1 | _aSalusky, Isidro B | |
700 | 1 | _aWesseling-Perry, Katherine | |
773 | 0 |
_tPloS one _gvol. 10 _gno. 3 _gp. e0120856 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1371/journal.pone.0120856 _zAvailable from publisher's website |
999 |
_c24711611 _d24711611 |